Fly News Breaks for March 10, 2015
ACT, AKRX
Mar 10, 2015 | 11:59 EDT
Piper Jaffray believes concerns around competition for clobetasol cream are overblown with shares of Akorn (AKRX) down 12% following the generic launch announcement from Actavis (ACT). Piper says it remains bullish on shares of Akorn.
News For AKRX;ACT From the Last 2 Days
There are no results for your query AKRX;ACT